Condition
Type 2 Diabetes Mellitus clinical trials and research
As of November 12, 2026, Find a Trial lists 42 Type 2 Diabetes Mellitus clinical trials that are recruiting, at sites in 36 countries (most in China (18), United States (15), Germany (7)). 2 were first registered in the last 30 days. By phase: Phase 3 (10), Phase 4 (3), Phase 2 (1), Phase 1 (1). The most active sponsors are AstraZeneca (5), Insulet Corporation (2), Nanjing First Hospital, Nanjing Medical University (2). There are also 14 NIH-funded research projects on Type 2 Diabetes Mellitus, with $6.9 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 42Clinical trials
- 14NIH research projects
- 2New in 30 days
- 36Countries
Newest Type 2 Diabetes Mellitus clinical trials
All recruiting trials (42)
-
Ocular Changes in People Using Tirzepatide or Semaglutide
This study checks whether eye structure and blood vessels change in adults with obesity who are taking semaglutide or tirzepatide as part of routine care.
-
Acupuncture plus vitamin B12 for diabetic heart nerve damage
This study tests whether adding acupuncture to standard care and vitamin B12 can help adults with type 2 diabetes who have damaged the nerves that control the heart.
-
Clinical decision support to help consider SGLT2 inhibitors after AKI in type 2 diabetes
This pilot test checks if a CDS message given to clinicians can help decide whether to consider SGLT2 inhibitors for adults with type 2 diabetes who recently had acute kidney injury.
-
Body composition changes after starting GLP-1 therapies in adults with obesity or type 2 diabetes
This study will follow adults with obesity and/or type 2 diabetes who are starting or adjusting a GLP-1 receptor agonist to see how their muscle and fat change over about a year.
-
Single-dose PK study of HRS-4729 in adults with and without kidney impairment
This study tests a single dose of HRS-4729 to see how the body handles it in adults with various levels of kidney function compared with healthy adults.
-
Once-daily ASC30 to See if it helps adults with obesity or overweight and Type 2 diabetes
This study tests three daily doses of ASC30 against placebo in adults who are overweight or obese and have Type 2 diabetes to see if it helps with weight loss and safety over time.
-
Canagliflozin for Type 2 Diabetes with Mild Cognitive Impairment
This study tests whether canagliflozin can help people with type 2 diabetes and mild cognitive impairment see if their thinking and memory improve.
-
Elecoglipron plus background insulin in adults with type 2 diabetes
This study tests whether adding Elecoglipron to existing insulin therapy helps adults with type 2 diabetes manage their blood sugar better than a placebo.
-
Can Elecoglipron help adults with type 2 diabetes compared with an existing medicine called semaglutide?
This study tests whether the pill Elecoglipron works as well as oral semaglutide in adults with type 2 diabetes who have added heart risk factors.
-
Elecoglipron vs placebo for adults with type 2 diabetes and impaired kidney function on dapagliflozin
This study tests whether elecoglipron can help adults with type 2 diabetes and kidney impairment who are taking or may take an SGLT2 inhibitor called dapagliflozin, in addition to their other diabetes medicines.
-
Combination therapy of Elecoglipron and Dapagliflozin in adults with type 2 diabetes
This trial tests whether the combination of Elecoglipron and Dapagliflozin works better than each drug alone to improve blood sugar control in adults with type 2 diabetes.
-
Elecoglipron with or without dapagliflozin in adults with type 2 diabetes
This study tests whether elecoglipron, alone or with dapagliflozin, helps adults with type 2 diabetes better control blood sugar than a placebo.
-
Automated Passive Case-Finding for Advanced Liver Fibrosis in MASLD
This program automatically screens high‑risk adults aged 50–75 in primary care to see if they have advanced liver fibrosis and possible MASLD, using routine blood tests and reflex lab tests without extra work for clinicians.
-
Omnipod 6 vs Omnipod 5: a head-to-head test in kids and adults with type 1 or type 2 diabetes
This study tests whether the Omnipod 6 system improves blood sugar control compared with the Omnipod 5 in people with type 1 or type 2 diabetes who aren’t at goal.
-
Finerenone in adults with CKD and type 2 diabetes in Spain: real-world changes in kidney risk score
This observational study tests how finerenone affects a kidney-risk score in adults with CKD linked to type 2 diabetes who are already taking finerenone in routine care in Spain.
-
HM15275 in adults with type 2 diabetes who have not yet reached goal
This phase 2 trial tests HM15275 or a placebo to see if it helps adults with type 2 diabetes improve blood sugar over 36 weeks.
-
Fully closed loop Omnipod M system in type 2 diabetes
This trial tests whether the Omnipod M fully closed-loop insulin system works safely and effectively for adults with type 2 diabetes who use insulin, compared with current therapy.
-
Structured management of adult cardiovascular risk factors in outpatient care
This project will try a structured clinic approach to managing blood pressure, cholesterol, diabetes, and weight in adults with cardiovascular risk factors to see if it improves risk control and outcomes.
-
Luseogliflozin (Lusefi) use in adults with type 2 diabetes
This non-interventional project will try Lusefi (luseogliflozin) in adults with type 2 diabetes to see how well it lowers blood sugar and how well patients tolerate it during routine care.
-
Carotid ultrasound wall texture to identify cardiovascular risk in Type 2 diabetes
This project will test whether carotid ultrasound measurements, including intima-media thickness and layer-specific wall texture, can help predict 10-year heart risk in adults aged 40–69 with Type 2 diabetes.
-
Pilot radiofrequency vapor ablation of the upper intestine for adults with type 2 diabetes
This pilot tests whether radiofrequency vapor ablation of the proximal intestine can improve blood sugar control in adults with type 2 diabetes who take non-insulin medications.
-
Enicepatide for weight management in people with overweight or obesity and type 2 diabetes
This trial tests whether enicepatide helps adults with overweight or obesity and type 2 diabetes lose weight compared with a placebo.
-
Targeting liver fat with the CMNT intermittent diet for people with type 2 diabetes and fatty liver
This study will try a CMNT intermittent energy‑restriction diet to see if lowering liver fat helps adults with type 2 diabetes and nonalcoholic fatty liver disease.
-
Evaluating the effects of finerenone on kidney function in patients with Type 2 diabetes and chronic kidney disease
This study is testing if adding a new kidney medication called finerenone can help people with Type 2 diabetes and chronic kidney disease improve their kidney function over 48 weeks.
-
Effects of eating dates on hunger and appetite in adults with Type 2 diabetes
This study tests if eating three Baghdad dates every day can help adults with Type 2 diabetes manage their hunger and appetite better over 12 weeks.
-
Assessing Islet Alpha Cell Function in Type 2 Diabetes Patients
This study is testing if a new diabetes treatment can help improve the function of certain cells in the pancreas for people who have just been diagnosed with type 2 diabetes.
-
Effect of Olive Pomace Oil on Blood Sugar Levels
This study is testing if adding olive pomace oil to meals can help people with type 2 diabetes or those at risk manage their blood sugar levels better.
-
Evaluating the Accu-Chek SmartGuide CGM for Diabetes Management
This study is testing if the Accu-Chek SmartGuide continuous glucose monitor can help adults with Type 1 or insulin-dependent Type 2 diabetes manage their blood sugar levels better than traditional self-monitoring methods.
-
Low protein diet combined with dapagliflozin for chronic kidney disease in type 2 diabetes patients
This study is testing if a low protein diet combined with the medication dapagliflozin can help people with type 2 diabetes and chronic kidney disease slow down their kidney problems.
-
Observational study on the use of finerenone for chronic kidney disease and type 2 diabetes
This study looks at how well finerenone works and how safe it is for people with chronic kidney disease and type 2 diabetes who are already taking it as part of their regular treatment.
-
Investigating how gene mutations affect diabetes susceptibility in patients
This study is testing how certain gene changes might affect the risk of developing Type 2 Diabetes in newly diagnosed patients compared to healthy individuals.
-
Investigating genetic factors affecting diabetes treatment response
This study is trying to see how genetic differences affect how well the diabetes drug exenatide works for Chinese patients with Type 2 Diabetes.
-
Evaluating a new combination therapy for high blood pressure and diabetes
This study is testing a new combination treatment for people with high blood pressure and type 2 diabetes to see if it works better and is safe compared to their current medications.
-
Using imaging to predict weight loss success after bariatric surgery
This study is testing if looking at CT scans of belly fat can help predict how much weight people will lose and if their type 2 diabetes will improve after bariatric surgery.
-
Understanding blood sugar control in patients with Left Ventricular Assist Devices
This study is trying to see if using a continuous glucose monitor gives better information about blood sugar control than traditional blood tests for people with Left Ventricular Assist Devices and type 2 diabetes.
-
Understanding chronic kidney disease in Sub-Saharan Africa
This study is trying to understand how common chronic kidney disease is in Sub-Saharan Africa and what factors might be causing it by looking at the health and lifestyle of adults in the Bagamoyo district.
-
Understanding Non-Alcoholic Fatty Liver Disease in Saudi Patients with Type 2 Diabetes
This study looks at how non-alcoholic fatty liver disease affects Saudi adults with type 2 diabetes over 10 years to see how the disease progresses and what factors might make it worse.
-
Effects of Tirzepatide and Insulin Glargine on Diabetes and Brain Function
This study tests whether the diabetes medications Tirzepatide and Insulin Glargine can improve blood sugar levels and brain function in people with type 2 diabetes.
-
Understanding how puberty affects kidney health in youth with diabetes
This study looks at how puberty affects kidney health in teenagers with type 2 diabetes and obesity to see if the changes during this time can harm their kidneys.
-
Madalena combination for treating type 2 diabetes
This trial will test whether the Madalena combination helps adults with type 2 diabetes who haven't reached blood sugar targets while on two medicines.
-
National Diabetes Management Program in China
This study is trying to create a nationwide database to help improve the care and understanding of diabetes in China by collecting health information and samples from patients.
-
Investigating nutritional and environmental factors in elderly health
This study is trying to find out how nutrition and the environment affect the health of older people living in Nanshan to help prevent diseases like high blood pressure and diabetes.
NIH-funded research (14)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Exploring new muscle chemistry in adults with Type 2 diabetes
A study will test a new imaging method to measure muscle metabolites in adults with Type 2 diabetes to better understand how the disease affects their muscles.
-
Save with Care: Help with costs to manage type 2 diabetes
A digital program helps adults with type 2 diabetes on high-deductible plans save money and get better access to care.
-
Predicting obesity-related diabetes and wound healing with math models
A math-based model is being built to better understand how obesity drives type 2 diabetes and slow wound healing in adults.
-
Improving heart- and kidney-protective treatment for people with type 2 diabetes and chronic kidney disease
This project will help people with type 2 diabetes and chronic kidney disease get proven medicines that protect the heart and kidneys but are often missed.
-
Personalized nutrition guided by continuous glucose monitors for type 2 diabetes
See whether using continuous glucose monitors to tailor meals helps adults with type 2 diabetes keep blood sugar under better control.
-
Reducing food insecurity for African American adults with diabetes
This study is looking at how not having enough food affects African American adults with Type 2 diabetes and is testing whether sending them food boxes or giving them food vouchers helps them manage their blood sugar better, or if using both together works best.
-
Understanding how diabetes affects insulin secretion in the body
This study is looking into why certain hormones that help your body produce insulin don't work as well in people with Type 2 Diabetes, and it hopes to find new ways to improve treatment for those living with the condition.
-
Improving brain barrier function in patients with type 2 diabetes
This study is looking at ways to help improve brain health in adults with type 2 diabetes by checking how well the blood-brain barrier is working and seeing if taking thiamine can make it better, which could help with thinking and mood.
-
Using continuous glucose monitoring to personalize nutrition for better diabetes management
This study is looking at how personalized meal plans, guided by real-time blood sugar monitoring, can help adults with type 2 diabetes manage their health better over 12 weeks, and it will compare these tailored plans to regular dietary advice to see which works best.
-
Understanding how Type-2 diabetes affects brain plasticity in older adults
This study is looking at how Type-2 diabetes affects the brain in older adults, especially how it changes the brain's ability to adapt and learn, and it's for older folks with diabetes who want to understand more about their brain health.
-
Improving heart and kidney treatment for patients with diabetes
This study is looking into why people with type 2 diabetes and chronic kidney disease aren't getting the heart-protecting treatments they need, and it aims to find ways to make sure these important medications are prescribed more often.
-
Creating a mathematical model to understand obesity-related diabetes and wound healing
This study is looking at how being overweight affects healing for people with type 2 diabetes, and it aims to create a helpful tool to better understand and improve care for those dealing with diabetes and slow-healing wounds.
-
Using tailored meals to help people with diabetes and food insecurity
This study is looking at how providing healthy, ready-to-eat meals can help people with type 2 diabetes who struggle to get enough food, and it also offers tips on managing their diabetes better.
-
How type 2 diabetes affects brain health and dementia risk
This study is looking at how not managing type 2 diabetes and prediabetes can affect brain health and memory in young adults aged 18 to 45, and it wants to find out if better diabetes management can help keep your mind sharp.
Related topics
Quick answers
How many Type 2 Diabetes Mellitus clinical trials are recruiting right now?
42, as of November 12, 2026. 2 of them were first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 36 countries. The most sites are in China (18 trials), United States (15 trials), Germany (7 trials), Japan (7 trials), Turkey (Türkiye) (7 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 10, Phase 4: 3, Phase 2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.